In 2018, cancer drugs earned the pharmaceutical industry $123.8 billion. Soon, they'll be worth billions more.
- A recent report from Evaluate shows oncological therapies were the most profitable in 2018.
- The report projects cancer drug sales to nearly double by 2024, pocketing a tidy $236.6 billion in profit.
- These projections come at a time when 42 percent of cancer patients lose their life savings to afford treatment.
Dr. Charles Grob was the first researcher granted FDA approval to study these drugs.
- Dr. Charles Grob began clinically studying ayahuasca and MDMA in the nineties, the first researcher to be granted FDA approval.
- Grob has also conducted studies on psilocybin and end-of-life care, which garnered great results.
- The future of psychedelics research is moving quickly thanks in large part to Grob's decades of clinical work.
A new study analyzed more than 1.5 billion opioid prescriptions over eight years.
- A new study analyzed over 1.5 billion opioid prescriptions between 2011 and 2018.
- Researchers discovered opioid prescription reductions of 11.8 percent and 4.2 percent in states that passed recreational and medical cannabis laws.
- The U.S. government needs to reschedule cannabis because researchers believe it has therapeutic value.
The move reflects a broader nationwide effort to lower prices of the life-saving drug.
- Some 30 million Americans have diabetes and must take insulin, but about 25 percent of them can't routinely afford the drug.
- In recent decades, the cost of insulin has skyrocketed, partly because only three companies make insulin in the U.S.
- There's some indication that recent efforts to make insulin more affordable are picking up steam.
Dr. Joel Smithers was recently sentenced to decades in prison for the numerous illegal prescriptions he gave out.
- According to law enforcement officials, every individual who visited Smithers' practice in Martinsville, Virginia, was given an opioid prescription.
- Patients traveled hundreds of miles to visit his practice, where Smithers only accepted cash or credit cards and not insurance.
- Smithers and similar doctors represent one part of the chain of responsible parties who contributed to the opioid epidemic.